Segments in this Video

Accessing Vaccines in African Slums (02:01)

FREE PREVIEW

In the African slums, disease is rampant and one third of the population lives with HIV; vaccinations are needed to lower the rates of preventable disease. Many mothers are forced to walk for several days to access basic health services and vaccinations for their newborns.

Vaccines in the Developing World (03:58)

Dr. Ciro de Quadros explains the function of vaccine companies when selling vaccines to the developing world; immunization and disease prevention is more cost effective than treatment. Historically, drug companies have few incentives to sell to the developing world.

Transforming the Vaccine Industry (05:01)

GlaxoSmithKline and the Mexican government collaborated to provide the developing world access to Rotarix. Dr. Roger Glass explains most vaccines are produced and developed in the U.S. or Europe.

How the GAVI Alliance Functions (03:37)

Julian Lob-Levyt, head of the GAVI Alliance, explains the development of the International Finance Facility for Immunization; the facility aims to raise bonds on the private market. European governments and investors plan to donate $4 million to the alliance.

Serum Institute of India (04:38)

The privately owned vaccine company creates and produces vaccines for the developing world. The pharmaceutical company aims to find cheaper, more efficient methods of producing existing vaccines to sell at a lower cost.

Credits: The Price of Life (00:39)

Credits: The Price of Life

For additional digital leasing and purchase options contact a media consultant at 800-257-5126
(press option 3) or sales@films.com.

The Price of Life

Part of the Series : Vaccine Hunters
DVD (Chaptered) Price: $129.95
DVD + 3-Year Streaming Price: $194.93
3-Year Streaming Price: $129.95

Share

Description

Vaccines are expensive and the funding is complex. From Big Pharmaceuticals to public sector, to universities, to NGOs, the UN, non-profit, not-for-profits and huge donations from private foundations, for the drug companies the trail from discovery to delivery requires deep pockets, a clear understanding of the market and ruthless commercial instincts. This program unpacks the way we pay for vaccines and looks at who benefits. Is this a business that just serves rich shareholders, or does it deliver vaccines to the poor who need them most? And what are the recipient countries themselves doing to pay the costs? Indeed, holding developing countries to account for where the money goes is a key part of building a better future between developed and developing countries.

Length: 22 minutes

Item#: BVL144786

Copyright date: ©2008

Closed Captioned

Performance Rights

Prices include public performance rights.

Not available to Home Video, Dealer and Publisher customers.


Share